fda approves semaglutide weight-loss drug Wegovy to reduce heart-disease risks FDA Warns on Certain Forms

- Easy to use without the worry of adding too much or too little water

Escalation: If tolerated, the dose is increased to the next level (e.g., 7 mg, then 14 mg) every 4 weeks

Ask your provider for a syringe size that makes your dose easy to identify

On the other hand, FDA-approved medications like Wegovy and Zepbound offer a proven path to weight loss with significantly lower risks

This function is defective in type 2 diabetes [7,8,9], presumably because DPP-4 activity is enhanced in patients with glucose intolerance [9,10,11]

As these weight-loss medications have gained popularity potentially helping obesity rates drop for the first time in a decade theyve also seemed to reduce patients alcohol use, too